Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Werewolf Therapeutics, Inc. (HOWL) had Debt to Capital Ratio of 0.32 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-18.09M |
|
-- |
|
-- |
|
$17.99M |
|
$-17.99M |
|
$-0.10M |
|
$-18.09M |
|
$-18.09M |
|
$-18.09M |
|
$-18.09M |
|
$-18.09M |
|
$-18.09M |
|
$-17.99M |
|
$-17.57M |
|
44.83M |
|
44.83M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$94.46M |
|
$5.90M |
|
$12.78M |
|
$107.24M |
|
$11.67M |
|
$26.59M |
|
$38.26M |
|
$49.93M |
|
$57.31M |
|
$57.31M |
|
$57.31M |
|
44.83M |
|
| Cash Flow Statement Financials | |
$-18.95M |
|
$0.00M |
|
$0.00M |
|
$112.22M |
|
$93.27M |
|
$-18.95M |
|
$2.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.09 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.32 |
0.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.95M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.57% |
|
-31.57% |
|
-16.87% |
|
-21.56% |
|
$1.28 |
|
$-0.42 |
|
$-0.42 |
|